» Articles » PMID: 37060516

Normative Profile of the EQ-5D-5L Dimensions, EQ-5D-5L Index and EQ-VAS Scores for the General Thai Population

Overview
Journal Qual Life Res
Date 2023 Apr 15
PMID 37060516
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To generate a normative profile for the EQ-5D-5L dimensions, EQ-5D-5L index, and EQ-VAS scores of the general Thai population and to examine the associations between sociodemographic characteristics and their norm-based scores.

Methods: Data from 2019 general Thai samples were employed to estimate the norm-based scores elicited using the Thai EQ-5D-5L value set. Descriptive statistics were used to estimate the norm-based scores stratified by gender and six age bands to obtain the normative profile for the general Thai population. Multivariable logistic and Tobit regression models were used to investigate the relationships between sociodemographic characteristics and EQ-5D-5L dimensions, EQ-5D-5L index, and EQ-VAS scores.

Results: The mean EQ-5D-5L index and EQ-VAS scores were 0.931 and 82.3, respectively. Approximately 88.9% of the participants reported 19 out of 3125 (3%) possible health states. The odds of having problems with mobility was greatest for the sample aged ≥ 65 years and declined with decreasing age. Women, samples with advancing age, and those with a household income of ≤ 10,000 Baht/month and fair and poor health perceptions were more likely to report a lower EQ-5D-5L index. Furthermore, advanced age and fair and poor health perception were significantly associated with lower EQ-VAS scores.

Conclusion: The EQ-5D-5L population norms were established as the benchmark for both EQ-5D-5L index and EQ-VAS scores for the general Thai population. This is expected to support the health service research and inform policymakers on the allocation of limited healthcare resources.

Citing Articles

Population norms for the EQ-5D-5L for Hungary: comparison of online surveys and computer assisted personal interviews.

Pentek M, Jager V, Kincses A, Holgyesi A, Zrubka Z, Baji P Eur J Health Econ. 2025; .

PMID: 39982665 DOI: 10.1007/s10198-024-01755-2.


Cost-utility and budget impact analysis of laparoscopic bariatric surgery for obesity with Type II Diabetes Mellitus in Thailand.

Noparatayaporn P, Thavorncharoensap M, Chaikledkaew U, Looareesuwan P, Shantavasinkul P, Sumritpradit P PLoS One. 2024; 19(12):e0315336.

PMID: 39656751 PMC: 11630598. DOI: 10.1371/journal.pone.0315336.


Norms for the EQ-5D-5L among the general adult population in Alberta, Canada.

Al Sayah F, Alam A, Short H, Ohinmaa A, Lahtinen M, Malo S Qual Life Res. 2024; 34(1):219-230.

PMID: 39487883 PMC: 11802591. DOI: 10.1007/s11136-024-03804-y.


Appropriateness of the EQ-5D-5L in capturing health-related quality of life in individuals with transfusion-dependent β-thalassemia: a mixed methods study.

Boateng-Kuffour A, Skrobanski H, Drahos J, Kohli P, Forster K, Acaster S Health Qual Life Outcomes. 2024; 22(1):54.

PMID: 38992661 PMC: 11241824. DOI: 10.1186/s12955-024-02265-8.


Comparing the EQ-5D-5L and stroke impact scale 2.0 in stroke patients: an analysis of measurement properties.

Schmidt J, Duvel J, Elkenkamp S, Greiner W Health Qual Life Outcomes. 2024; 22(1):45.

PMID: 38835023 PMC: 11151530. DOI: 10.1186/s12955-024-02252-z.


References
1.
Brooks R . EuroQol: the current state of play. Health Policy. 1996; 37(1):53-72. DOI: 10.1016/0168-8510(96)00822-6. View

2.
Nordlund A, Ekberg K, Kristenson M . EQ-5D in a general population survey--a description of the most commonly reported EQ-5D health states using the SF-36. Qual Life Res. 2005; 14(4):1099-109. DOI: 10.1007/s11136-004-3062-2. View

3.
Marti-Pastor M, Pont A, Avila M, Garin O, Vilagut G, Forero C . Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys. Popul Health Metr. 2018; 16(1):14. PMC: 6097421. DOI: 10.1186/s12963-018-0170-8. View

4.
Sassi F . Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan. 2006; 21(5):402-8. DOI: 10.1093/heapol/czl018. View

5.
Rawlins M, Culyer A . National Institute for Clinical Excellence and its value judgments. BMJ. 2004; 329(7459):224-7. PMC: 487742. DOI: 10.1136/bmj.329.7459.224. View